House Oversight Again Probing White House Opioid Strategy

By Chelsea Cirruzzo / February 5, 2020 at 12:01 PM
The House Oversight & Reform Committee is already probing the Trump administration’s national drug strategy that was released Monday (Feb. 4), continuing the work of the late Chair Elijah Cummings (D-MD) who last year questioned the White House Office of National Drug Control Policy (ONDCP) on what he called an inadequate strategy. The office’s national drug strategy came out Monday, quickly followed by an announcement from the House Oversight & Reform Committee that it will be holding a hearing later...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.